Dianthus Therapeutics, Inc. /DE/ Quarterly Current Ratio in % from Q1 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Current Ratio history and growth rate from Q1 2019 to Q3 2024.
  • Dianthus Therapeutics, Inc. /DE/ Current Ratio for the quarter ending September 30, 2024 was 2.73K %, a 96.5% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 2.73K +1.34K +96.5% Sep 30, 2024
Q2 2024 2.68K +1.47K +122% Jun 30, 2024
Q1 2024 2.32K +1.18K +103% Mar 31, 2024
Q4 2023 1.62K +512 +46.1% Dec 31, 2023
Q3 2023 1.39K +373 +36.7% Sep 30, 2023
Q2 2023 1.21K -36.7 -2.95% Jun 30, 2023
Q1 2023 1.15K -272 -19.2% Mar 31, 2023
Q4 2022 1.11K -429 -27.9% Dec 31, 2022
Q3 2022 1.02K -639 -38.6% Sep 30, 2022
Q2 2022 1.24K -346 -21.8% Jun 30, 2022
Q1 2022 1.42K -127 -8.2% Mar 31, 2022
Q4 2021 1.54K +123 +8.66% Dec 31, 2021
Q3 2021 1.66K +323 +24.2% Sep 30, 2021
Q2 2021 1.59K +248 +18.5% Jun 30, 2021
Q1 2021 1.54K +183 +13.4% Mar 31, 2021
Q4 2020 1.42K -105 -6.87% Dec 31, 2020
Q3 2020 1.33K -325 -19.6% Sep 30, 2020
Q2 2020 1.34K -216 -13.9% Jun 30, 2020
Q1 2020 1.36K -274 -16.8% Mar 31, 2020
Q4 2019 1.52K Dec 31, 2019
Q3 2019 1.66K Sep 30, 2019
Q2 2019 1.56K Jun 30, 2019
Q1 2019 1.63K Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.